# Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction

> **NCT00006062** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 60 (—)

## Conditions studied

- Liver Disease

## Interventions

- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00006062
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** —
- **Final completion:** 2001-05
- **Target enrollment:** 60 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006062, "Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00006062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*